Abstract:This study describes the discovery of a unique salt-cocrystal of the active pharmaceutical ingredient (API) ponatinib hydrochloride (pon), and characterization using single-crystal X-ray diffraction (SCXRD) and solid-state NMR (SSNMR) spectroscopy. Pon is a multicomponent crystal that features an unusual stoichiometry, with an asymmetric unit containing both monocations and dications of the ponatinib molecule, three water molecules, and three chloride ions. Structural features include (i) a charged imidazopyridazine moiety that forms a hydrogen bond between the ponatinib monocations and dications and (ii) a chloride ion that does not feature hydrogen bonds involving any organic moiety, instead being situated in a "square" arrangement with three water molecules. Multinuclear SSNMR, featuring high and ultra-high fields up to 35.2 T, provides the groundwork for structural interpretations of complex multicomponent crystals in the absence of diffraction data. For example, a 13C CP/MAS spectrum confirms the presence of two crystallographically distinct ponatinib molecules, whereas 1D 1H and 2D 1H–1H DQ–SQ spectra identify and assign the unusually deshielded imidazopyridazine 1H peak. 1D 35Cl spectra obtained at multiple fields confirm the presence of three distinct chloride ions, with density functional theory calculations providing key relationships between the SSNMR spectra and H···Cl– hydrogen bonding arrangements. A 2D 35Cl→1H D-RINEPT spectrum confirms the spatial proximities between the chloride ions, water molecules, and amine moieties. This all suggests future applications of multinuclear SSNMR at high and ultra-high fields to the study of complex API solid forms for which SCXRD data are unavailable, with potential application to heterogeneous mixtures or amorphous solid dispersions.

Two Anhydrous Forms and One Monohydrate of a Cocrystal of Axitinib and Glutaric Acid: Characterization, Property Evaluation and Phase Transition Study

Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior

Tuning the physicochemical properties of axitinib by crystallization: Preparation, calculation and Structure-property relationship

Solvates and Polymorphs of Axitinib: Characterization and Phase Transformation

Study of Crystal Structures, Properties, and Form Transformations among a Polymorph, Hydrates, and Solvates of Apatinib

Polymorphs and Hydrates of Apatinib Mesylate: Insight into the Crystal Structures, Properties, and Phase Transformations

Structural Insights into the Highly Solvating System of Axitinib via Binary and Ternary Solvates

Solid-State Characterization and Insight into Transformations and Stability of Apatinib Mesylate Solvates

Impact of Crystal Habit on Solubility of Ticagrelor

Mechanism of solvent-mediated polymorphic transformation to prepare axitinib form XLI controlled by water activity

Cocrystals of regorafenib with dicarboxylic acids: synthesis, characterization and property evaluation

Stable Cocrystals and Salts of the Antineoplastic Drug Apatinib with Improved Solubility in Aqueous Solution

Terahertz and Raman Spectroscopic Investigation of Monohydrate Cocrystal of Antitubercular Isoniazid with Protocatechuic Acid

Improving physicochemical properties of Ibrutinib with cocrystal strategy based on structures and natures of the carboxylic acid co-formers

Assessing Structures and Solution Behaviors of Molecular and Ionic Cocrystals with a Common Bioactive Molecule: 2,4-Pyridinedicarboxylic Acid with Tranexamic Acid and Nicotinamide

A novel drug-drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Distinguishing Polymorphs of Ethenzamide-Saccharin Cocrystal Based on Terahertz and Raman Vibrational Spectroscopic Techniques

A Drug–Drug Cocrystal of Dihydromyricetin and Pentoxifylline

An Unusual Ionic Cocrystal of Ponatinib Hydrochloride: Characterization by Single-Crystal X-ray Diffraction and Ultra-High Field NMR Spectroscopy

Exploring Solid Form Landscape of Anticancer Drug Dimethylaminomicheliolide Fumarate: Crystal Structures Analysis, Phase Transformation Behavior, and Physicochemical Properties Characterization